Crossmark

Prospective study of thyroid functions in multiple sclerosis patients treated with interferon beta in Alexandria University MS clinic

Published Online: 2021-02-01

Published Print: 2021-12

Authors

Talaat, Farouk

Eldeeb, Hany http://orcid.org/0000-0001-8667-8514
License Information

Text and Data Mining valid from 2021-02-01

Version of Record valid from 2021-02-01
More Information

Article History

Received: 12 May 2020

Accepted: 18 January 2021

First Online: 1 February 2021

Ethics approval and consent to participate

: Ethical approval was obtained from the Ethics Committee (EC) of the Alexandria Faculty of Medicine which is constituted and operates according to the International Conference on Harmonisation-Good Clinical Practice ICH GCP guidelines (Food and Drug Administration guideline) and applicable local and institutional regulations and guidelines which govern EC operation. The approval was obtained by the monthly meeting of EC on 11th February 2018. There is no registry number for the ethics committee acceptance. Informed written consents were taken from the patients before participation in the study.

: Not applicable

: The authors declare that they have no competing interests.

Document is current